587 related articles for article (PubMed ID: 18697435)
1. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
2. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.
Jain R; Danziger LH
Ann Pharmacother; 2004 Sep; 38(9):1449-59. PubMed ID: 15280512
[TBL] [Abstract][Full Text] [Related]
4. Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
Kendirli T; Aydín HI; Hacíhamdioğlu D; Gülgün M; Unay B; Akín R; Lenk MK; Gökçay E
J Hosp Infect; 2004 Apr; 56(4):328. PubMed ID: 15066747
[No Abstract] [Full Text] [Related]
5. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
Katragkou A; Roilides E
J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
[No Abstract] [Full Text] [Related]
7. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002].
Akan OA
Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260
[TBL] [Abstract][Full Text] [Related]
8. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.
Jiménez-Mejías ME; Pichardo-Guerrero C; Márquez-Rivas FJ; Martín-Lozano D; Prados T; Pachón J
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):212-4. PubMed ID: 11957024
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
López-Hernández S; Alarcón T; López-Brea M
Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706
[TBL] [Abstract][Full Text] [Related]
11. Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam.
Jiménez-Mejías ME; Pachón J; Becerril B; Palomino-Nicás J; Rodríguez-Cobacho A; Revuelta M
Clin Infect Dis; 1997 May; 24(5):932-5. PubMed ID: 9142795
[TBL] [Abstract][Full Text] [Related]
12. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas.
Paramythiotou E; Karakitsos D; Aggelopoulou H; Sioutos P; Samonis G; Karabinis A
Med Mal Infect; 2007 Feb; 37(2):124-5. PubMed ID: 17270377
[TBL] [Abstract][Full Text] [Related]
13. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.
Urban C; Segal-Maurer S; Rahal JJ
Clin Infect Dis; 2003 May; 36(10):1268-74. PubMed ID: 12746772
[TBL] [Abstract][Full Text] [Related]
14. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis.
Fulnecky EJ; Wright D; Scheld WM; Kanawati L; Shoham S
J Infect; 2005 Dec; 51(5):e249-51. PubMed ID: 15913780
[TBL] [Abstract][Full Text] [Related]
15. High dose of intrathecal netilmicin in the treatment of nosocomial Acinetobacter baumannii meningitis.
Buke C; Sipahi OR; Yurtseven T; Zileli M
J Infect; 2005 Dec; 51(5):420-2. PubMed ID: 16321655
[No Abstract] [Full Text] [Related]
16. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
Plachouras D; Giamarellos-Bourboulis EJ; Kentepozidis N; Baziaka F; Karagianni V; Giamarellou H
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):419-22. PubMed ID: 17188449
[TBL] [Abstract][Full Text] [Related]
17. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
[TBL] [Abstract][Full Text] [Related]
18. [Intrathecal use of colistin].
Charra B; Hachimi A; Benslama A; Motaouakkil S
Ann Fr Anesth Reanim; 2006 Feb; 25(2):215. PubMed ID: 16311006
[No Abstract] [Full Text] [Related]
19. Treatment of pan-drug resistant Acinetobacter baumannii.
Lee CM; Lim HK; Liu CP; Tseng HK
Scand J Infect Dis; 2005; 37(3):195-9. PubMed ID: 15849052
[TBL] [Abstract][Full Text] [Related]
20. Colistin, meropenem and rifampin in a combination therapy for multi-drug-resistant Acinetobacter baumannii multifocal infection. A case report.
Biancofiore G; Tascini C; Bisà M; Gemignani G; Bindi ML; Leonildi A; Giannotti G; Menichetti F
Minerva Anestesiol; 2007 Mar; 73(3):181-5. PubMed ID: 17159765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
